Advertisement

Reactions Weekly

, Volume 1780, Issue 1, pp 55–55 | Cite as

Avelumab/ipilimumab/nivolumab

Myositis: 2 case reports
Case report
  • 68 Downloads

Reference

  1. Delyon J, et al. Immune checkpoint inhibitor rechallenge in patients with immune-related myositis. Annals of the Rheumatic Diseases 78: No. 11, Nov 2019. Available from: URL: http://doi.org/10.1136/annrheumdis-2018-214336 - FranceCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations